A Study Investigating the Association of Dermatological and Infusion Reactions to Infliximab and Infliximab Trough Levels

A Study Investigating the Association of Dermatological and Infusion Reactions to Infliximab and Infliximab Trough Levels

BACKGROUND: Although infliximab is an effective therapy for inflammatory bowel disease (IBD), it is associated with dermatological events and infusion reactions. It is not known whether a relationship between these adverse events (AEs) and infliximab trough levels (ITLs) exists.

Bibliographic Details
Main Authors: Vivian Wai-Mei Huang, Neil Dhami, Darryl Fedorak, Connie Prosser, Carol Shalapay, Karen Ivy Kroeker, Brendan Phillip Halloran, Levinus Albert Dieleman, Richard Neil Fedorak
Format: Article
Language:English
Published: Hindawi Limited 2015-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2015/428702
Description
Summary:BACKGROUND: Although infliximab is an effective therapy for inflammatory bowel disease (IBD), it is associated with dermatological events and infusion reactions. It is not known whether a relationship between these adverse events (AEs) and infliximab trough levels (ITLs) exists.
ISSN:2291-2789
2291-2797

Similar Items